{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T15:08:42Z","timestamp":1793286522779,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["20-13-00402"],"award-info":[{"award-number":["20-13-00402"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.ejmech.2021.113997","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T06:36:08Z","timestamp":1637130968000},"page":"113997","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Synthesis, biological evaluation, and in silico studies of potential activators of apoptosis and carbonic anhydrase inhibitors on isatin-5-sulfonamide scaffold"],"prefix":"10.1016","volume":"228","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8367-9500","authenticated-orcid":false,"given":"Stepan K.","family":"Krymov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2974-9555","authenticated-orcid":false,"given":"Alexander M.","family":"Scherbakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0809-3710","authenticated-orcid":false,"given":"Diana I.","family":"Salnikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danila V.","family":"Sorokin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyubov G.","family":"Dezhenkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan V.","family":"Ivanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Vullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3314-2411","authenticated-orcid":false,"given":"Clemente","family":"Capasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4262-0323","authenticated-orcid":false,"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6595-0811","authenticated-orcid":false,"given":"Andrey E.","family":"Shchekotikhin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejmech.2021.113997_bib1","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/carcin\/21.3.485","article-title":"Apoptosis in cancer","volume":"21","author":"Lowe","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ejmech.2021.113997_bib2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1756-9966-30-87","article-title":"Apoptosis in cancer: from pathogenesis to treatment","volume":"30","author":"Wong","year":"2011","journal-title":"J.\u00a0Exp. Clin. Cancer Res."},{"issue":"20","key":"10.1016\/j.ejmech.2021.113997_bib3","doi-asserted-by":"crossref","first-page":"5914","DOI":"10.1158\/0008-5472.CAN-16-1248","article-title":"Finally, an apoptosis-targeting therapeutic for cancer","volume":"76","author":"Croce","year":"2016","journal-title":"Cancer Res."},{"issue":"18","key":"10.1016\/j.ejmech.2021.113997_bib4","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1021\/jm900722z","article-title":"Procaspase-3 activation as an anti-cancer strategy: structure-activity relationship of procaspase-activating compound 1 (PAC-1) and its cellular Co-localization with caspase-3","volume":"52","author":"Peterson","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113997_bib5","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nchembio814","article-title":"Small-molecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategy","volume":"2","author":"Putt","year":"2006","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2021.113997_bib6","unstructured":"Clinical Trial Information NCT02355535."},{"issue":"13","key":"10.1016\/j.ejmech.2021.113997_bib7","doi-asserted-by":"crossref","first-page":"7533","DOI":"10.1073\/pnas.1031631100","article-title":"Direct activation of the apoptosis machinery as a mechanism to target cancer cells","volume":"100","author":"Nguyen","year":"2003","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"issue":"21","key":"10.1016\/j.ejmech.2021.113997_bib8","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.1021\/jm0704189","article-title":"An investigation into the cytotoxicity and mode of action of some novel N-Alkyl-Substituted isatins","volume":"50","author":"Vine","year":"2007","journal-title":"J.\u00a0Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2021.113997_bib9","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2174\/1871520610909040397","article-title":"Cytotoxic and anticancer activities of isatin and its derivatives: a comprehensive review from 2000-2008","volume":"9","author":"Vine","year":"2009","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113997_bib10","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ejmech.2018.11.017","article-title":"Pharmaceutical and medicinal significance of sulfur (SVI)-Containing motifs for drug discovery: a critical review","volume":"162","author":"Zhao","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2021.113997_bib11","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2021.113997_bib12","series-title":"The Organic Chemistry of Drug Design and Drug Action","author":"Silverman","year":"2014"},{"issue":"2","key":"10.1016\/j.ejmech.2021.113997_bib13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/cbic.201600513","article-title":"Structure\u2013activity relationships of benzenesulfonamide-based inhibitors towards carbonic anhydrase isoform specificity","volume":"18","author":"Bhatt","year":"2017","journal-title":"Chembiochem"},{"issue":"12","key":"10.1016\/j.ejmech.2021.113997_bib14","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1002\/jps.1157","article-title":"Hydrogen bonding in sulfonamides","volume":"90","author":"Adsmond","year":"2001","journal-title":"J.\u00a0Pharmaceut. Sci."},{"issue":"3","key":"10.1016\/j.ejmech.2021.113997_bib15","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.radonc.2011.05.045","article-title":"Specific inhibition of carbonic anhydrase IX activity enhances the in\u00a0vivo therapeutic effect of tumor irradiation","volume":"99","author":"Dubois","year":"2011","journal-title":"Radiother. Oncol."},{"issue":"6","key":"10.1016\/j.ejmech.2021.113997_bib16","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1021\/jm101541x","article-title":"Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis","volume":"54","author":"Pacchiano","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"issue":"10","key":"10.1016\/j.ejmech.2021.113997_bib17","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1042\/CS20210040","article-title":"Emerging role of carbonic anhydrase inhibitors","volume":"135","author":"Supuran","year":"2021","journal-title":"Clin. Sci."},{"issue":"8","key":"10.1016\/j.ejmech.2021.113997_bib18","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2021.113997_bib19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10555-019-09799-0","article-title":"The role of carbonic anhydrase IX in cancer development: links to hypoxia, acidosis, and beyond","volume":"38","author":"Pastorekova","year":"2019","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.ejmech.2021.113997_bib20","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.febslet.2004.10.043","article-title":"Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH","volume":"577","author":"Svastova","year":"2004","journal-title":"FEBS Lett."},{"issue":"19","key":"10.1016\/j.ejmech.2021.113997_bib21","doi-asserted-by":"crossref","first-page":"7146","DOI":"10.3390\/ijms21197146","article-title":"Carbonic anhydrase IX in renal cell carcinoma, implications for disease management","volume":"21","author":"Courcier","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.ejmech.2021.113997_bib22","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/s41416-018-0216-5","article-title":"Carbonic anhydrase IX is a pH-stat that sets an acidic tumour extracellular pH in\u00a0vivo","volume":"119","author":"Lee","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejmech.2021.113997_bib23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cbpa.2015.02.005","article-title":"Targeting carbonic anhydrase IX with small organic ligands","volume":"26","author":"Wichert","year":"2015","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113997_bib24","doi-asserted-by":"crossref","first-page":"84","DOI":"10.18632\/oncotarget.422","article-title":"Recent developments in targeting carbonic anhydrase IX for cancer therapeutics","volume":"3","author":"McDonald","year":"2012","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.ejmech.2021.113997_bib25","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1158\/0008-5472.CAN-10-4261","article-title":"Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors","volume":"71","author":"Lou","year":"2011","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.ejmech.2021.113997_bib26","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.radonc.2013.06.018","article-title":"Targeting carbonic anhydrase IX by nitroimidazole based sulfamides enhances the therapeutic effect of tumor irradiation: a new concept of dual targeting drugs","volume":"108","author":"Dubois","year":"2013","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ejmech.2021.113997_bib27","doi-asserted-by":"crossref","first-page":"112923","DOI":"10.1016\/j.ejmech.2020.112923","article-title":"Recent advances in the medicinal chemistry of carbonic anhydrase inhibitors","volume":"209","author":"Kumar","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113997_bib28","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ejmech.2017.07.073","article-title":"Novel 4\/3-((4-oxo-5-(2-oxoindolin-3-ylidene)thiazolidin-2-ylidene)amino) benzenesulfonamides: synthesis, carbonic anhydrase inhibitory activity, anticancer activity and molecular modelling studies","volume":"139","author":"Eldehna","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113997_bib29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejmech.2018.10.068","article-title":"Enhancement of the tail hydrophobic interactions within the carbonic anhydrase IX active site via structural extension: design and synthesis of novel N-substituted isatins-SLC-0111 hybrids as carbonic anhydrase inhibitors and antitumor agents","volume":"162","author":"Eldehna","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113997_bib30","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.bioorg.2018.09.007","article-title":"Tumor-associated carbonic anhydrase isoform IX and XII inhibitory properties of certain isatin-bearing sulfonamides endowed with in\u00a0vitro antitumor activity towards colon cancer","volume":"81","author":"Eldehna","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113997_bib31","doi-asserted-by":"crossref","first-page":"6973","DOI":"10.1021\/jm049637+","article-title":"Drug evolution concept in drug design: 1. Hybridization method","volume":"47","author":"Lazar","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113997_bib32","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1021\/ja038606l","article-title":"A\u00a0highly potent non-nucleoside adenosine deaminase inhibitor. Efficient drug discovery by intentional lead hybridization","volume":"126","author":"Terasaka","year":"2004","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2021.113997_bib33","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ejmech.2019.02.010","article-title":"Molecular hybridization approach for phenothiazine incorporated 1,2,3-triazole hybrids as promising antimicrobial agents: design, synthesis, molecular docking and in silico ADME studies","volume":"168","author":"Reddyrajula","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113997_bib34","doi-asserted-by":"crossref","first-page":"111665","DOI":"10.1016\/j.ejmech.2019.111665","article-title":"Design and synthesis of novel artemisinin derivatives with potent activities against colorectal cancer in\u00a0vitro and in\u00a0vivo","volume":"182","author":"Wang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113997_bib35","doi-asserted-by":"crossref","first-page":"112457","DOI":"10.1016\/j.ejmech.2020.112457","article-title":"Exploration of carbamide derived pyrimidine-thioindole conjugates as potential VEGFR-2 inhibitors with anti-angiogenesis effect","volume":"200","author":"Sana","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113997_bib36","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1021\/jm0600287","article-title":"Indanesulfonamides as carbonic anhydrase inhibitors. Toward structure-based design of selective inhibitors of the tumor-associated isozyme CA IX","volume":"49","author":"Thiry","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"issue":"12","key":"10.1016\/j.ejmech.2021.113997_bib37","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1021\/jm0100537","article-title":"Potent and selective nonpeptide inhibitors of caspases 3 and 7","volume":"44","author":"Lee","year":"2001","journal-title":"J.\u00a0Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113997_bib38","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/hlca.19190020125","article-title":"\u00dcber Isonitrosoacetanilide und deren Kondensation zu Isatinen","volume":"2","author":"Sandmeyer","year":"1919","journal-title":"Helv. Chim. Acta"},{"key":"10.1016\/j.ejmech.2021.113997_bib39","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/ajh.2830380309","article-title":"Induction of carbonic anhydrase I isozyme precedes the globin synthesis during erythropoiesis in K562 cells","volume":"38","author":"Kondo","year":"1991","journal-title":"Am. J. Hematol."},{"issue":"34","key":"10.1016\/j.ejmech.2021.113997_bib40","first-page":"998","article-title":"Expression of carbonic anhydrase I or II and correlation to clinical aspects of colorectal cancer","volume":"47","author":"Bekku","year":"2000","journal-title":"Hepato-Gastroenterology"},{"key":"10.1016\/j.ejmech.2021.113997_bib41","first-page":"2240","article-title":"The expression of carbonic anhydrase II in hematological malignancies","volume":"8","author":"Leppilampi","year":"2002","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.ejmech.2021.113997_bib42","doi-asserted-by":"crossref","first-page":"6776","DOI":"10.18632\/oncotarget.2882","article-title":"Carbonic anhydrase XII is a new therapeutic target to overcome chemoresistance in cancer cells","volume":"6","author":"Kopecka","year":"2015","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.ejmech.2021.113997_bib43","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.ejcb.2010.03.004","article-title":"Carbonic anhydrase XII promotes invasion and migration ability of MDA-MB-231 breast cancer cells through the p38 MAPK signaling pathway","volume":"89","author":"Hsieh","year":"2010","journal-title":"Eur. J. Cell Biol."},{"issue":"4","key":"10.1016\/j.ejmech.2021.113997_bib44","first-page":"2585","article-title":"Cellular and radiobiological effects of carbonic anhydrase IX in human breast cancer cells","volume":"41","author":"G\u00fcttler","year":"2019","journal-title":"Oncol. Rep."},{"issue":"10","key":"10.1016\/j.ejmech.2021.113997_bib45","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3390\/metabo10100412","article-title":"Carbonic anhydrase inhibitors targeting metabolism and tumor microenvironment","volume":"10","author":"Angeli","year":"2020","journal-title":"Metabolites"},{"issue":"3","key":"10.1016\/j.ejmech.2021.113997_bib46","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ejmech.2005.12.004","article-title":"Synthesis of 3-substituted-2-oxoindole analogues and their evaluation as kinase inhibitors, anticancer and antiangiogenic agents","volume":"41","author":"Abadi","year":"2006","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113997_bib47","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.biochi.2020.12.024","article-title":"Heteroarene-fused anthraquinone derivatives as potential modulators for human aurora kinase B","volume":"182","author":"Singh","year":"2021","journal-title":"Biochimie"},{"issue":"6","key":"10.1016\/j.ejmech.2021.113997_bib48","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.celrep.2019.09.079","article-title":"Aryl sulfonamides degrade RBM39 and RBM23 by recruitment to CRL4-DCAF15","volume":"29","author":"Ting","year":"2019","journal-title":"Cell Rep."},{"issue":"6","key":"10.1016\/j.ejmech.2021.113997_bib49","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/nchembio.2363","article-title":"Selective degradation of splicing factor CAPER\u03b1 by anticancer sulfonamides","volume":"13","author":"Uehara","year":"2017","journal-title":"Nat. Chem. Biol."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113997_bib50","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10549-008-0217-9","article-title":"MCF-7 breast carcinoma cells do not express caspase-3","volume":"117","author":"J\u00e4nicke","year":"2009","journal-title":"Breast Cancer Res. Treat."},{"issue":"6","key":"10.1016\/j.ejmech.2021.113997_bib51","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/sj.cdd.4400851","article-title":"Characterization of the necrotic cleavage of poly(ADP-ribose) polymerase (PARP-1): implication of lysosomal proteases","volume":"8","author":"Gobeil","year":"2001","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejmech.2021.113997_bib52","doi-asserted-by":"crossref","first-page":"524308","DOI":"10.1155\/2012\/524308","article-title":"The role of BCL2 family of apoptosis regulator proteins in acute and chronic leukemias","volume":"2012","author":"Tzifi","year":"2012","journal-title":"Adv. Hematol."},{"issue":"4720","key":"10.1016\/j.ejmech.2021.113997_bib53","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1126\/science.3929382","article-title":"The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining","volume":"229","author":"Tsujimoto","year":"1985","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.ejmech.2021.113997_bib54","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0960-9822(06)00046-7","article-title":"Apoptosis: activate NF-\u03baB or die?","volume":"7","author":"Baichwal","year":"1997","journal-title":"Curr. Biol."},{"issue":"10","key":"10.1016\/j.ejmech.2021.113997_bib55","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1172\/JCI26322","article-title":"IKK\/NF-kappaB signaling: balancing life and death-a new approach to cancer therapy","volume":"115","author":"Luo","year":"2005","journal-title":"J.\u00a0Clin. Invest."},{"issue":"6","key":"10.1016\/j.ejmech.2021.113997_bib56","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/sj.cdd.4400528","article-title":"NF-kappaB functions as both a proapoptotic and antiapoptotic regulatory factor within a single cell type","volume":"6","author":"Lin","year":"1999","journal-title":"Cell Death Differ."},{"issue":"3","key":"10.1016\/j.ejmech.2021.113997_bib57","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1042\/bj20020752","article-title":"Activation of nuclear factor-kappaB during doxorubicin-induced apoptosis in endothelial cells and myocytes is pro-apoptotic: the role of hydrogen peroxide","volume":"367","author":"Wang","year":"2002","journal-title":"Biochem. J."},{"issue":"9","key":"10.1016\/j.ejmech.2021.113997_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006992","article-title":"Addressing reported pro-apoptotic functions of NF-kappaB: targeted inhibition of canonical NF-kappaB enhances the apoptotic effects of doxorubicin","volume":"4","author":"Bednarski","year":"2009","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ejmech.2021.113997_bib59","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.febslet.2005.12.012","article-title":"NF-kappaB activation is required for cisplatin-induced apoptosis in head and neck squamous carcinoma cells","volume":"580","author":"Kim","year":"2006","journal-title":"FEBS Lett."},{"issue":"3","key":"10.1016\/j.ejmech.2021.113997_bib60","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.3390\/curroncol28030168","article-title":"Current landscape of targeted therapy in hormone receptor-positive and HER2-negative breast cancer","volume":"28","author":"Andrahennadi","year":"2021","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.ejmech.2021.113997_bib61","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1016\/j.bmc.2007.01.034","article-title":"Naphthoindolebased analogues of tryptophan and tryptamine: synthesis and cytotoxic properties","volume":"15","author":"Shchekotikhin","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113997_bib62","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/07357907.2018.1453072","article-title":"Novel quinoxaline-2-carbonitrile-1,4-dioxide derivatives suppress HIF1\u03b1 activity and circumvent MDR in cancer cells","volume":"36","author":"Scherbakov","year":"2018","journal-title":"Cancer Invest."},{"key":"10.1016\/j.ejmech.2021.113997_bib63","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J.\u00a0Biol. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113997_bib64","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/14756366.2021.1882453","article-title":"Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase","volume":"36","author":"Nocentini","year":"2021","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2021.113997_bib65","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1021\/acs.jmedchem.9b01130","article-title":"Bioisosteric development of multitarget nonsteroidal anti-inflammatory drug-carbonic anhydrases inhibitor hybrids for the management of rheumatoid arthritis","volume":"63","author":"Bua","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2021.113997_bib66","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.bmc.2016.01.005","article-title":"Cloning, characterization and anion inhibition studies of a gamma-carbonic anhydrase from the Antarctic bacterium Colwellia psychrerythraea","volume":"24","author":"De Luca","year":"2016","journal-title":"Bioorg. Med. Chem."},{"issue":"16","key":"10.1016\/j.ejmech.2021.113997_bib67","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1016\/j.bmc.2016.05.029","article-title":"Anion inhibition profiles of alpha-, beta- and gamma-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae","volume":"24","author":"Del Prete","year":"2016","journal-title":"Bioorg. Med. Chem."},{"issue":"18","key":"10.1016\/j.ejmech.2021.113997_bib68","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1016\/j.bmc.2016.07.034","article-title":"Anion inhibition profiles of the complete domain of the eta-carbonic anhydrase from Plasmodium falciparum","volume":"24","author":"Del Prete","year":"2016","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113997_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-005-9075-x","article-title":"Activation of mitogenic pathways and sensitization to estrogen-induced apoptosis: two independent characteristics of tamoxifen-resistant breast cancer cells?","volume":"100","author":"Scherbakov","year":"2006","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ejmech.2021.113997_bib70","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A\u00a0rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"issue":"2","key":"10.1016\/j.ejmech.2021.113997_bib71","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4161\/spmg.1.2.16606","article-title":"Enhanced chemiluminescence (ECL) for routine immunoblotting: an inexpensive alternative to commercially available kits","volume":"1","author":"Mruk","year":"2011","journal-title":"Spermatogenesis"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421008461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421008461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:34:34Z","timestamp":1759329274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421008461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":71,"alternative-id":["S0223523421008461"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113997","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis, biological evaluation, and in silico studies of potential activators of apoptosis and carbonic anhydrase inhibitors on isatin-5-sulfonamide scaffold","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113997","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113997"}}